These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38578212)

  • 21. High incidence of venous thromboembolism recurrence in patients with sickle cell disease.
    Brunson A; Keegan T; Mahajan A; White R; Wun T
    Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
    Brunson A; Lei A; Rosenberg AS; White RH; Keegan T; Wun T
    Br J Haematol; 2017 Jul; 178(2):319-326. PubMed ID: 28369826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study.
    Roberts MZ; Gaskill GE; Kanter-Washko J; Kyle TR; Jones BC; Bohm NM
    J Thromb Thrombolysis; 2018 May; 45(4):512-515. PubMed ID: 29556958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study.
    Forté S; De Luna G; Abdulrehman J; Fadiga N; Pestrin O; Pham Hung d'Alexandry d'Orengiani AL; Aneke JC; Guillet H; Budhram D; Habibi A; Ward R; Bartolucci P; Kuo KHM
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis for the prothrombotic state in sickle cell disease.
    Shet AS; Lizarralde-Iragorri MA; Naik RP
    Haematologica; 2020 Oct; 105(10):2368-2379. PubMed ID: 33054077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.
    Noubiap JJ; Temgoua MN; Tankeu R; Tochie JN; Wonkam A; Bigna JJ
    Thromb J; 2018; 16():27. PubMed ID: 30305805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interventions for chronic kidney disease in people with sickle cell disease.
    Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy-related thromboembolism in women with sickle cell disease: An analysis of National Medicaid Data.
    Agarwal S; Stanek JR; Vesely SK; Creary SE; Cronin RM; Roe AH; O'Brien SH
    Am J Hematol; 2023 Nov; 98(11):1677-1684. PubMed ID: 37551881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sickle Cell Disease and Thromboembolism: New Insights on the Pathophysiology, Diagnosis, and Treatment.
    Dobie G
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients.
    Christen JR; Bertolino J; Jean E; Camoin L; Ebbo M; Harlé JR; Schleinitz N; Sarlon G; Bernit E
    Hemoglobin; 2019; 43(4-5):296-299. PubMed ID: 31724442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review.
    Raslan IA; Solh Z; Kuo KHM; Abdulrehman J
    Hemoglobin; 2024 Jul; 48(4):231-243. PubMed ID: 39420740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Rankine-Mullings AE; Nevitt SJ
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002202. PubMed ID: 36047926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and venous thromboembolism risk in patients with sickle cell disease.
    Singh A; Brandow AM; Wun T; Shet AS
    Blood Adv; 2022 Aug; 6(15):4408-4412. PubMed ID: 35763429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.
    Pakbaz Z; Wun T
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):355-74. PubMed ID: 24589271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.
    Faes C; Ilich A; Sotiaux A; Sparkenbaugh EM; Henderson MW; Buczek L; Beckman JD; Ellsworth P; Noubouossie DF; Bhoopat L; Piegore M; Renoux C; Bergmeier W; Park Y; Ataga KI; Cooley B; Wolberg AS; Key NS; Pawlinski R
    Blood; 2019 Jun; 133(23):2529-2541. PubMed ID: 30952675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
    Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative Thromboprophylaxis Is Associated With Lower Risk of Venous Thromboembolism After Knee Arthroscopy.
    Holler JT; Salesky M; Halvorson RT; Zhang AL; Ma CB; Feeley BT; Leavitt AD; Colyvas N; Lansdown DA
    Arthroscopy; 2022 Dec; 38(12):3184-3191. PubMed ID: 35840070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.